Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1229111a198f86af4112ecd730b55cd9 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y603-02003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-93 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P13-00 |
filingDate |
2014-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60d6cb9674a4fc955e20093b1148bf8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2de4d77040d3d8d1e15e100eb2b0d91e |
publicationDate |
2015-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
IN-2014CH02384-A |
abstract |
The invention relates to a prokaryotic microorganism strain capable of overproducing ?-glutamyl¬cysteine and its derivatives bis-?-glutamylcystine and ?-glutamyl¬cystine, which can be prepared from a parent strain, wherein said strain has a reduced cellular glutathione synthetase activity compared to the parent strain, and has a cellular ?-glutamylcysteine synthetase activity which is more greatly increased than in a strain with similarly reduced cellular glutathione synthetase activity. |
priorityDate |
2013-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |